Viatris Inc (VTRS) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Viatris Inc

NASDAQ | VTRS

7.64

USD

-0.52 (-6.37%)

AT CLOSE (AS OF Apr 4, 2025)

$9.7B

MARKET CAP

P/E Ratio

-0.53

EPS

$13

52 Week High

$8.1

52 Week Low

LIFE SCIENCES

Sector

VTRS Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

VTRS Technicals

Tags:

VTRS Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	$6.4B
Total Revenue	$15B
Cost Of Revenue	$9B
Costof Goods And Services Sold	$9B
Operating Income	$766M
Selling General And Administrative	$4.7B
Research And Development	$805M
Operating Expenses	$5.7B
Investment Income Net	-
Net Interest Income	-$573M
Interest Income	-
Interest Expense	$573M
Non Interest Income	$15B
Other Non Operating Income	$9.8M
Depreciation	$362M
Depreciation And Amortization	$2.3B
Income Before Tax	$203M
Income Tax Expense	$148M
Interest And Debt Expense	$573M
Net Income From Continuing Operations	$55M
Comprehensive Income Net Of Tax	$69M
Ebit	$766M
Ebitda	$3.1B
Net Income	$55M

Revenue & Profitability

Earnings Performance

VTRS Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2023)

Field	Value (USD)
Total Assets	$48B
Total Current Assets	$13B
Cash And Cash Equivalents At Carrying Value	$992M
Cash And Short Term Investments	$1B
Inventory	$3.5B
Current Net Receivables	$2.8B
Total Non Current Assets	$35B
Property Plant Equipment	$2.8B
Accumulated Depreciation Amortization Ppe	$2B
Intangible Assets	$29B
Intangible Assets Excluding Goodwill	$19B
Goodwill	$9.9B
Investments	$86M
Long Term Investments	$1.1B
Short Term Investments	$37M
Other Current Assets	$271M
Other Non Current Assets	$2.2B
Total Liabilities	$27B
Total Current Liabilities	$7.8B
Current Accounts Payable	$1.9B
Deferred Revenue	-
Current Debt	$1.9B
Short Term Debt	$2B
Total Non Current Liabilities	$16B
Capital Lease Obligations	$248M
Long Term Debt	$35B
Current Long Term Debt	$1.9B
Long Term Debt Noncurrent	$16B
Short Long Term Debt Total	$35B
Other Current Liabilities	$3.4B
Other Non Current Liabilities	$1.5B
Total Shareholder Equity	$20B
Treasury Stock	$252M
Retained Earnings	$4.6B
Common Stock	$12M
Common Stock Shares Outstanding	$1.2B

yearly Cash Flow (As of Dec 31, 2023)

Field	Value (USD)
Operating Cashflow	$2.8B
Payments For Operating Activities	$1.3B
Proceeds From Operating Activities	-
Change In Operating Liabilities	$238M
Change In Operating Assets	$535M
Depreciation Depletion And Amortization	$2.7B
Capital Expenditures	$377M
Change In Receivables	-$79M
Change In Inventory	$613M
Profit Loss	$55M
Cashflow From Investment	-$764M
Cashflow From Financing	-$2.3B
Proceeds From Repayments Of Short Term Debt	$300K
Payments For Repurchase Of Common Stock	$250M
Payments For Repurchase Of Equity	$250M
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$576M
Dividend Payout Common Stock	$576M
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	$3.1M
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	$300K
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$247M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$55M

yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	$6.4B
Total Revenue	$15B
Cost Of Revenue	$9B
Costof Goods And Services Sold	$9B
Operating Income	$766M
Selling General And Administrative	$4.7B
Research And Development	$805M
Operating Expenses	$5.7B
Investment Income Net	-
Net Interest Income	-$573M
Interest Income	-
Interest Expense	$573M
Non Interest Income	$15B
Other Non Operating Income	$9.8M
Depreciation	$362M
Depreciation And Amortization	$2.3B
Income Before Tax	$203M
Income Tax Expense	$148M
Interest And Debt Expense	$573M
Net Income From Continuing Operations	$55M
Comprehensive Income Net Of Tax	$69M
Ebit	$766M
Ebitda	$3.1B
Net Income	$55M

Dividends

Field	Value
Ex Dividend Date	2025-03-10
Declaration Date	2025-02-27
Record Date	2025-03-10
Payment Date	2025-03-18
Amount	0.12

VTRS Profile

Viatris Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.

Most Active

Symbol	Price	Change %	Market Cap	Volume
NVDA	$94.01	-7.66%	$2.68T	373,302,836
MULN	$0.08	-0.25%	$422.46K	337,586,718
DMN	$0.01	-9.93%	-	250,076,428
WCT	$0.28	45.18%	$100.86M	188,340,447
TSLA	$240.53	-10.01%	$909.50B	142,548,074

See more →

Symbol	Price	Change %	Market Cap	Volume
JNJ	$154.56	-3.29%	$399.65B	7,875,932
PG	$165.33	-4.10%	$399.61B	7,816,658
ABBV	$189.45	-6.05%	$364.89B	6,531,310
NVO	$62.56	-6.77%	$308.32B	8,022,008
ABT	$124.98	-5.06%	$228.39B	6,215,349

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
AEHL	$3.69	6,928.57%	$3.18M	5,236,630
SOBR	$5.18	1,390.92%	$396.44K	1,133,038
FTFT	$1.35	948.14%	$3.27M	173,315
CISS	$4.00	592.64%	$2.68M	439,024
AREB	$10.90	175.25%	$3.77M	75,956,361

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
MMV	$0.48	-51.02%	$11.90M	1,568,644
KRBP	$0.16	-48.72%	$424.82K	107,749